Elisabeth Åvall‐Lundqvist

4.7k total citations · 2 hit papers
76 papers, 2.7k citations indexed

About

Elisabeth Åvall‐Lundqvist is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Elisabeth Åvall‐Lundqvist has authored 76 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Reproductive Medicine, 32 papers in Oncology and 30 papers in Obstetrics and Gynecology. Recurrent topics in Elisabeth Åvall‐Lundqvist's work include Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (30 papers) and Cancer survivorship and care (10 papers). Elisabeth Åvall‐Lundqvist is often cited by papers focused on Ovarian cancer diagnosis and treatment (31 papers), Endometrial and Cervical Cancer Treatments (30 papers) and Cancer survivorship and care (10 papers). Elisabeth Åvall‐Lundqvist collaborates with scholars based in Sweden, Germany and United States. Elisabeth Åvall‐Lundqvist's co-authors include Gunnar Steineck, Karin Bergmark, Lars Henningsohn, Paul W. Dickman, Gail Dunberger, Ann‐Charlotte Waldenström, Elisabet Hjerpe, Tommy Nyberg, Jordi Ponce and Christhardt Köhler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Elisabeth Åvall‐Lundqvist

75 papers receiving 2.7k citations

Hit Papers

Vaginal Changes and Sexuality in Women with a History of ... 1999 2026 2008 2017 1999 2018 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Vaginal Changes and Sexuality in Women with a History of Cervical Cancer
    1999 542 citations Elisabeth Åvall‐Lundqvist, Lars Henningsohn et al. profile →
  2. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
    2018 340 citations Elisabeth Åvall‐Lundqvist, Sandro Pignata et al. International Journal of Gynecological Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Åvall‐Lundqvist Sweden 26 1.3k 1.1k 973 683 504 76 2.7k
Sarah E. Ferguson Canada 31 768 0.6× 1.6k 1.4× 1.3k 1.3× 540 0.8× 370 0.7× 161 3.0k
Cor D. de Kroon Netherlands 34 768 0.6× 1.7k 1.5× 1.3k 1.3× 632 0.9× 393 0.8× 118 3.4k
Lee-may Chen United States 30 1.3k 1.0× 924 0.8× 1.5k 1.6× 543 0.8× 273 0.5× 110 3.4k
Bengt Sorbe Sweden 30 634 0.5× 1.6k 1.4× 1.5k 1.6× 761 1.1× 467 0.9× 133 3.0k
Patricia L. Judson United States 25 1.2k 0.9× 904 0.8× 1.4k 1.4× 850 1.2× 607 1.2× 68 3.4k
Ritu Salani United States 36 1.3k 1.1× 1.8k 1.6× 2.3k 2.3× 1.3k 1.9× 660 1.3× 165 4.6k
Susan C. Modesitt United States 36 1.0k 0.8× 1.1k 1.0× 1.3k 1.3× 760 1.1× 416 0.8× 130 3.7k
Jubilee Brown United States 32 877 0.7× 1.2k 1.1× 1.6k 1.6× 825 1.2× 408 0.8× 130 3.3k
Ernest I. Kohorn United States 36 488 0.4× 1.2k 1.0× 1.1k 1.2× 653 1.0× 390 0.8× 87 3.1k
Parviz Hanjani United States 27 651 0.5× 1.1k 1.0× 1.1k 1.1× 451 0.7× 285 0.6× 59 2.4k

Countries citing papers authored by Elisabeth Åvall‐Lundqvist

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Åvall‐Lundqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Åvall‐Lundqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Åvall‐Lundqvist more than expected).

Fields of papers citing papers by Elisabeth Åvall‐Lundqvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Åvall‐Lundqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Åvall‐Lundqvist. The network helps show where Elisabeth Åvall‐Lundqvist may publish in the future.

Co-authorship network of co-authors of Elisabeth Åvall‐Lundqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Åvall‐Lundqvist. A scholar is included among the top collaborators of Elisabeth Åvall‐Lundqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Åvall‐Lundqvist. Elisabeth Åvall‐Lundqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roncolato, Felicia, Madeleine King, Rachel O’Connell, et al.. (2024). Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer. Gynecologic Oncology. 185. 128–137. 3 indexed citations
2.
Engvall, K., et al.. (2024). Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencing. npj Precision Oncology. 8(1). 102–102. 2 indexed citations
3.
Dahm‐Kähler, Pernilla, Angelique Flöter Rådestad, Erik Holmberg, et al.. (2024). Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study. Gynecologic Oncology. 186. 69–76. 2 indexed citations
4.
Engvall, K., Henrik Gréen, Mats Fredrikson, et al.. (2022). Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study. Breast Cancer Research and Treatment. 195(3). 379–391. 23 indexed citations
5.
Marcickiewicz, Janusz, Christer Borgfeldt, Maria Bjurberg, et al.. (2021). Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—A Swedish Gynecologic Cancer Group (SweGCG) study. Acta Obstetricia Et Gynecologica Scandinavica. 100(8). 1526–1533. 23 indexed citations
6.
Åvall‐Lundqvist, Elisabeth, et al.. (2021). Patterns of recurrence and survival in vulvar cancer: A nationwide population-based study. Gynecologic Oncology. 161(3). 748–754. 19 indexed citations
7.
Hellman, Kristina, Erik Holmberg, Maria Bjurberg, et al.. (2020). Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study. Gynecologic Oncology. 159(3). 663–671. 14 indexed citations
8.
Lindemann, Kristina, Emma Gibbs, Elisabeth Åvall‐Lundqvist, et al.. (2017). Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist). British Journal of Cancer. 116(4). 455–463. 36 indexed citations
9.
Roncolato, Felicia, Dominique Berton-Rigaud, Rachel O’Connell, et al.. (2017). Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS). Gynecologic Oncology. 148(1). 36–41. 30 indexed citations
10.
Dahm‐Kähler, Pernilla, Christer Borgfeldt, Erik Holmberg, et al.. (2016). Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG). Gynecologic Oncology. 144(1). 167–173. 18 indexed citations
11.
12.
Hjerpe, Elisabet, Suzanne Egyházi, Joseph W. Carlson, et al.. (2013). HSP60 Predicts Survival in Advanced Serous Ovarian Cancer. International Journal of Gynecological Cancer. 23(3). 448–455. 43 indexed citations
13.
Dunberger, Gail, et al.. (2013). Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning. Supportive Care in Cancer. 21(11). 3063–3070. 87 indexed citations
14.
Leandro‐García, Luis J., Susanna Leskelä, Carlos Jara, et al.. (2012). Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy. Clinical Cancer Research. 18(16). 4441–4448. 57 indexed citations
15.
Lind, Helena, Massoud al‐Abany, Caroline Olsson, et al.. (2012). Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy. Acta Oncologica. 52(4). 719–726. 12 indexed citations
16.
Dunberger, Gail, Ann‐Charlotte Waldenström, Helena Lind, et al.. (2012). Cancer survivors’ perception of participation in a long-term follow-up study. Journal of Medical Ethics. 39(1). 41–45. 15 indexed citations
17.
Waldenström, Ann‐Charlotte, Caroline Olsson, Ulrica Wilderäng, et al.. (2010). Pain and Mean Absorbed Dose to the Pubic Bone After Radiotherapy Among Gynecological Cancer Survivors. International Journal of Radiation Oncology*Biology*Physics. 80(4). 1171–1180. 22 indexed citations
18.
Dunberger, Gail, Helena Lind, Gunnar Steineck, et al.. (2010). Fecal Incontinence Affecting Quality of Life and Social Functioning Among Long-Term Gynecological Cancer Survivors. International Journal of Gynecological Cancer. 20(3). 449–460. 49 indexed citations
19.
Dunberger, Gail, Helena Lind, Gunnar Steineck, et al.. (2009). Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. European Journal of Cancer. 46(3). 606–615. 62 indexed citations
20.
Silins, Ilvars, Elisabeth Åvall‐Lundqvist, Amha Tadesse, et al.. (2002). Evaluation of Antibodies to Human Papillomavirus as Prognostic Markers in Cervical Cancer Patients. Gynecologic Oncology. 85(2). 333–338. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah E. Ferguson Breakdown of academic impact, for papers by Cor D. de Kroon Breakdown of academic impact, for papers by Lee-may Chen Breakdown of academic impact, for papers by Bengt Sorbe Breakdown of academic impact, for papers by Patricia L. Judson Breakdown of academic impact, for papers by Ritu Salani Breakdown of academic impact, for papers by Susan C. Modesitt Breakdown of academic impact, for papers by Jubilee Brown Breakdown of academic impact, for papers by Ernest I. Kohorn Breakdown of academic impact, for papers by Parviz Hanjani
Rankless by CCL
2026